Related Experiment Video
Updated: Apr 1, 2026
03:43
Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
702
Cannabinoids, cannabinoid receptors and tinnitus
1Dept. of Pharmacology and Toxicology, School of Medical Sciences, University of Otago Medical School, Dunedin, New Zealand.
Hearing Research
|October 4, 2015
Summary
Tinnitus may be a form of sensory epilepsy. This review explores if cannabinoid drugs, which have anti-epileptic effects, could help or worsen tinnitus by affecting the cochlear nucleus.
Area of Science:
- Neuroscience
- Pharmacology
- Otolaryngology
Background:
- Tinnitus is hypothesized to be a form of sensory epilepsy, potentially caused by neuronal hyperactivity in auditory brain regions like the cochlear nucleus.
- Current drug treatments for tinnitus are limited, though anti-epileptic drugs are sometimes used.
- Cannabinoid receptor agonists show potential anti-epileptic effects in certain brain areas.
Purpose of the Study:
- To investigate the potential pro- or anti-epileptic effects of cannabinoid receptor agonists in the cochlear nucleus.
- To determine if cannabinoids and Cannabis could alleviate or exacerbate tinnitus symptoms.
Main Methods:
- Review of existing evidence on cannabinoid CB1 receptors and 2-arachidonylglycerol (2-AG) expression in the cochlear nucleus.
- Analysis of the role of these endogenous cannabinoids in neural plasticity.
- Exploration of the literature regarding the anti-epileptic properties of cannabinoid receptor agonists.
Main Results:
- Cannabinoid CB1 receptors and 2-AG are present in the cochlear nucleus and modulate plasticity.
- The precise effect of cannabinoid receptor agonists (pro- or anti-epileptic) in the cochlear nucleus remains to be fully elucidated.
- The potential impact of cannabinoids on tinnitus is complex and requires further investigation.
Conclusions:
- The role of cannabinoids in tinnitus treatment is uncertain, with potential for both benefit and harm.
- Understanding cannabinoid effects on cochlear nucleus excitability is crucial for assessing their therapeutic potential for tinnitus.
- Further research is needed to clarify the efficacy and safety of cannabinoids for tinnitus management.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
935
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
935
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.2K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.2K
01:22Opioid Receptors: Overview
6.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.6K
01:25Analgesia and Pain Management
3.0K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.0K
01:27Tactile and Chemical Senses
1.3K
Tactile senses encompass touch, temperature, and pain, each mediated by specific receptors. Touch receptors detect mechanical energy or pressure against the skin. Sensory fibers from these receptors enter the spinal cord and relay information to the brain stem. Here, most fibers cross over to the opposite side of the brain. The touch information then moves to the thalamus, which projects a map of the body's surface onto the somatosensory areas of the parietal lobes in the cerebral cortex.
1.3K
01:44Nociception
34.7K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
34.7K